ECSP088634A - Metodos para tratar infecciones del tracto gastrointestinal con tigeciclina - Google Patents
Metodos para tratar infecciones del tracto gastrointestinal con tigeciclinaInfo
- Publication number
- ECSP088634A ECSP088634A EC2008008634A ECSP088634A ECSP088634A EC SP088634 A ECSP088634 A EC SP088634A EC 2008008634 A EC2008008634 A EC 2008008634A EC SP088634 A ECSP088634 A EC SP088634A EC SP088634 A ECSP088634 A EC SP088634A
- Authority
- EC
- Ecuador
- Prior art keywords
- methods
- tigecicline
- gastrointestinal tract
- tract infections
- treat gastrointestinal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
En la presente se describen métodos para tratar al menos una infección bacteriana, tal como infecciones gastrointestinales inferiores, que comprenden administrar oralmente una composición farmacéutica que comprende tigeciclina. La composición puede tomar formas sólidas o líquidas, tal como soluciones, dispersiones o formas sólidas que comprenden tigeciclina que tiene al menos un revestimiento entérico.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75316105P | 2005-12-22 | 2005-12-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP088634A true ECSP088634A (es) | 2008-08-29 |
Family
ID=37963595
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2008008634A ECSP088634A (es) | 2005-12-22 | 2008-07-18 | Metodos para tratar infecciones del tracto gastrointestinal con tigeciclina |
Country Status (15)
Country | Link |
---|---|
US (1) | US20070243244A1 (es) |
EP (1) | EP1962860A1 (es) |
JP (1) | JP2009521456A (es) |
KR (1) | KR20080085184A (es) |
CN (1) | CN101340917A (es) |
AU (1) | AU2006331685A1 (es) |
BR (1) | BRPI0620430A2 (es) |
CA (1) | CA2631632A1 (es) |
CR (1) | CR10023A (es) |
EC (1) | ECSP088634A (es) |
GT (1) | GT200800115A (es) |
IL (1) | IL191598A0 (es) |
NO (1) | NO20082396L (es) |
RU (1) | RU2008121238A (es) |
WO (1) | WO2007075792A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0611070A2 (pt) * | 2005-05-06 | 2010-08-03 | Wyeth Corp | composição; composição farmacêutica; terapia de combinação; aparelho médico; método para a administração de pelo menos uma glicilciclina e pelo menos uma heparina; método para a administração de glicilciclina e heparina; método de tratamento de infecções intra-abdominais com complicações (ciai) e infecções cutáneas e da estrutura cutánea com complicações (csssi) causadas por patógenos gram negativos e gram positivos, anaeróbios e cepas tanto suscetìveis a meticilina quanto aquelas resistentes a meticilina de staphylococcus aureus (mssa e mrsa); método de tratamento de infecções intra-abdominais com complicações (ciai) e infecções cutáneas e da estrutura cutánea com complicações (csssi) causadas por patógenos gram negativos e gram positivos, anaeróbios e cepas tanto suscetìveis a meticilina quanto as resistentes a meticilina de staphylococcus aureus (mssa e mrsa) em um paciente que dele necessite; método de administração de antibiótico; artigo de fabricação; kit; uso de uma glicilcilina de fórmula i ou seu sal farmaceuticamente aceitável; uso de uma heparina ou seu sal farmaceuticamente aceitável; e produto |
WO2009143150A2 (en) * | 2008-05-19 | 2009-11-26 | Burnham Institute For Medical Research | Intestinal alkaline phosphatase modulators and uses thereof |
RU2647972C2 (ru) * | 2010-05-12 | 2018-03-21 | Ремпекс Фармацеутикалс, Инк. | Тетрациклиновая композиция |
CN103356662B (zh) * | 2012-03-27 | 2015-11-25 | 浙江医药股份有限公司新昌制药厂 | 注射用替加环素组合物及其制备方法 |
CN103263400B (zh) * | 2013-01-16 | 2014-12-17 | 内蒙古金河动物药业有限公司 | 一种金霉素微囊制剂及其制备方法 |
ES2774962T3 (es) | 2013-03-05 | 2020-07-23 | Enteris Biopharma Inc | Productos farmacéuticos de administración oral |
DK3244878T3 (da) | 2015-01-12 | 2022-10-17 | Enteris Biopharma Inc | Faste orale sammensætningsformer |
BR112018069303A2 (pt) * | 2016-03-24 | 2019-01-22 | Paratek Pharm Innc | método para tratamento de uma infecção |
CN111166729A (zh) * | 2020-03-19 | 2020-05-19 | 珠海赛隆药业股份有限公司 | 一种口服的替加环素肠溶微球及其制备方法 |
CN112843071A (zh) * | 2020-09-08 | 2021-05-28 | 天津国际生物医药联合研究院 | 土霉素或者替加环素在抗分枝杆菌感染中的潜在应用 |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3026248A (en) * | 1959-09-11 | 1962-03-20 | Pfizer & Co C | Thioglycerol and formaldehyde sulfoxylate stabilized tetracycline antibiotics in polyhydric alcohol solvents |
US3219529A (en) * | 1962-10-04 | 1965-11-23 | American Cyanamid Co | Stable tetracycline solutions |
US5494903A (en) * | 1991-10-04 | 1996-02-27 | American Cyanamid Company | 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines |
US5281628A (en) * | 1991-10-04 | 1994-01-25 | American Cyanamid Company | 9-amino-7-(substituted)-6-demethyl-6-deoxytetracyclines |
US5167964A (en) * | 1992-02-14 | 1992-12-01 | Warner-Lambert Company | Semi-enteric drug delivery systems and methods for preparing same |
US5420272A (en) * | 1992-08-13 | 1995-05-30 | American Cyanamid Company | 7-(substituted)-8-(substituted)-9-](substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines |
SG47520A1 (en) * | 1992-08-13 | 1998-04-17 | American Cyanamid Co | New method for the production of 9-amino-6-demethyl-6-deoxytetracycline |
US5328902A (en) * | 1992-08-13 | 1994-07-12 | American Cyanamid Co. | 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines |
US5284963A (en) * | 1992-08-13 | 1994-02-08 | American Cyanamid Company | Method of producing 7-(substituted)-9-[(substituted glycyl)-amidol]-6-demethyl-6-deoxytetra-cyclines |
JP2784847B2 (ja) * | 1994-02-17 | 1998-08-06 | ファイザー インク. | 9−(置換アミノ)−アルファ−6−デオキシ−5−オキシテトラサイクリン誘導体、それらの製造及び、抗生物質としてのそれらの使用 |
US5675030A (en) * | 1994-11-16 | 1997-10-07 | American Cyanamid Company | Method for selective extracting a 7-(hydrogen or substituted amino)-9- (substituted glycyl) amido!-6-demethyl-6-deoxytetracycline compound |
US5567693A (en) * | 1994-12-13 | 1996-10-22 | American Cyanamid Company | Method for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growth |
US6063775A (en) * | 1997-04-29 | 2000-05-16 | Berman; Charles L. | Retardation of metalloproteinase incidental to HIV and/or AIDS |
US5908838A (en) * | 1998-02-19 | 1999-06-01 | Medics Pharmaceutical Corporation | Method for the treatment of acne |
US6015803A (en) * | 1998-05-04 | 2000-01-18 | Wirostko; Emil | Antibiotic treatment of age-related macular degeneration |
US6015804A (en) * | 1998-09-11 | 2000-01-18 | The Research Foundation Of State University Of New York | Method of using tetracycline compounds to enhance interleukin-10 production |
US5998390A (en) * | 1998-09-28 | 1999-12-07 | The Research Foundation Of State University Of New York | Combination of bisphosphonate and tetracycline |
US6506740B1 (en) * | 1998-11-18 | 2003-01-14 | Robert A. Ashley | 4-dedimethylaminotetracycline derivatives |
US20040131628A1 (en) * | 2000-03-08 | 2004-07-08 | Bratzler Robert L. | Nucleic acids for the treatment of disorders associated with microorganisms |
WO2001074761A1 (en) * | 2000-03-31 | 2001-10-11 | Trustees Of Tufts College | 7-and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds |
KR100699390B1 (ko) * | 2000-07-07 | 2007-03-28 | 트러스티즈 오브 터프츠 칼리지 | 9-치환된 미노사이클린 화합물 |
CN102336679A (zh) * | 2000-07-07 | 2012-02-01 | 塔夫茨大学信托人 | 7-取代的四环素化合物 |
MXPA03008165A (es) * | 2001-03-13 | 2003-12-12 | Paratek Pharm Innc | Compuestos tetraciclina sustituidos en la posicion 7,9. |
US6841546B2 (en) * | 2001-03-14 | 2005-01-11 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds as antifungal agents |
WO2003005971A2 (en) * | 2001-07-13 | 2003-01-23 | Paratek Pharmaceuticals, Inc. | Tetracycline compounds having target therapeutic activities |
EP1474380A4 (en) * | 2002-01-08 | 2007-04-18 | Paratek Pharm Innc | 4-DESDIMETHYL AMINO TETRA CYCLINE COMPOUNDS |
US6958161B2 (en) * | 2002-04-12 | 2005-10-25 | F H Faulding & Co Limited | Modified release coated drug preparation |
EP1534300A4 (en) * | 2002-07-12 | 2008-04-23 | Paratek Pharm Innc | TETRACYCLINE COMPOUNDS SUBSTITUTED IN 3, 10, AND 12A |
AU2003274927A1 (en) * | 2002-08-23 | 2004-03-11 | Genome Therapeutics Corporation | Methods and reagents for preventing bacteremias |
ES2339003T3 (es) * | 2002-08-29 | 2010-05-14 | Activbiotics Pharma Llc | Rifalazil para tratar infecciones por clostridium difficile. |
US20050148553A1 (en) * | 2003-09-05 | 2005-07-07 | Testa Raymond T. | Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis |
-
2006
- 2006-12-20 WO PCT/US2006/048617 patent/WO2007075792A1/en active Application Filing
- 2006-12-20 JP JP2008547492A patent/JP2009521456A/ja active Pending
- 2006-12-20 EP EP06847831A patent/EP1962860A1/en not_active Withdrawn
- 2006-12-20 BR BRPI0620430-9A patent/BRPI0620430A2/pt not_active Application Discontinuation
- 2006-12-20 CN CNA2006800477777A patent/CN101340917A/zh active Pending
- 2006-12-20 CA CA002631632A patent/CA2631632A1/en not_active Abandoned
- 2006-12-20 KR KR1020087017967A patent/KR20080085184A/ko not_active Application Discontinuation
- 2006-12-20 AU AU2006331685A patent/AU2006331685A1/en not_active Abandoned
- 2006-12-20 RU RU2008121238/14A patent/RU2008121238A/ru not_active Application Discontinuation
- 2006-12-21 US US11/642,522 patent/US20070243244A1/en not_active Abandoned
-
2008
- 2008-05-21 IL IL191598A patent/IL191598A0/en unknown
- 2008-05-27 CR CR10023A patent/CR10023A/es not_active Application Discontinuation
- 2008-05-27 NO NO20082396A patent/NO20082396L/no not_active Application Discontinuation
- 2008-06-19 GT GT200800115A patent/GT200800115A/es unknown
- 2008-07-18 EC EC2008008634A patent/ECSP088634A/es unknown
Also Published As
Publication number | Publication date |
---|---|
BRPI0620430A2 (pt) | 2011-11-08 |
NO20082396L (no) | 2008-08-26 |
WO2007075792A1 (en) | 2007-07-05 |
CR10023A (es) | 2008-08-21 |
CN101340917A (zh) | 2009-01-07 |
JP2009521456A (ja) | 2009-06-04 |
EP1962860A1 (en) | 2008-09-03 |
GT200800115A (es) | 2009-01-16 |
KR20080085184A (ko) | 2008-09-23 |
RU2008121238A (ru) | 2010-01-27 |
US20070243244A1 (en) | 2007-10-18 |
CA2631632A1 (en) | 2007-07-05 |
IL191598A0 (en) | 2009-08-03 |
AU2006331685A1 (en) | 2007-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP088634A (es) | Metodos para tratar infecciones del tracto gastrointestinal con tigeciclina | |
CL2007003686A1 (es) | Compuestos derivados de indol con anillo unido en las posiciones 4,5; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para tratar una infeccion viral. | |
IL250858A0 (en) | Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections | |
HK1138184A1 (en) | Combination medicaments for treating bacterial infections | |
BR112012010270A2 (pt) | mentisulfonilmetano (msm) para tratamento de micro-organismos resistentes a fármaco | |
EA201791850A1 (ru) | Борсодержащие малые молекулы | |
CL2013002417A1 (es) | Compuestos derivados de fluoropiridinona; composición farmacéutica que los comprende; y su uso en el tratamiento de infecciones bacterianas. | |
CL2007003192A1 (es) | Compuestos derivados de arilamidas sustituidas por tiazol u oxazol; composicion farmaceutica; y uso para el tratamiento de una enfermedad del tracto urinario. | |
BRPI0717822A2 (pt) | Composto, processo de fabricação de composto da fórmula i, composição farmacêutica, método de tratamento e/ou profilaxia de doenças que são associadas à modulação de receptores de cb2 e uso de composto. | |
EA021554B9 (ru) | Органические соединения и их применение для лечения hcv инфекции | |
WO2015024010A3 (en) | Substituted hydroxamic acid compounds | |
WO2012031298A3 (en) | Ethynylbenzene derivatives | |
CL2011003327A1 (es) | Composicion farmaceutica que comprende finafloxacina y un agente antiinflamatorio; uso en el tratamiento de infecciones oftalmicas, oticas o nasales. | |
EA201200484A1 (ru) | Фармацевтическая композиция с действующими веществами - метформином и ситаглиптином или вилдаглиптином | |
UY32424A (es) | Comprimidos conteniendo elivitegravir para tratamiento de infecciones virales | |
CL2011000165A1 (es) | Compuestos derivados de indolinonas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento y/o la prevencion del cancer, infecciones, enfermedades inflamatorias y autoinmunes. | |
BR112012021931A2 (pt) | composto, composição farmacêutica, método para tratar uma infecção bacteriana, e, uso de composto | |
CL2008001728A1 (es) | Compuestos derivados de indolinonas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de cancer, infecciones, enfermedades inflamatorias y autoinmunes. | |
CL2007001542A1 (es) | Compuestos derivados de aminotiazoles, composicion farmaceutica; y uso para el tratamiento de infecciones bacterianas. | |
CL2007003847A1 (es) | Compuestos derivados de pirimidinas 2,4,5 tri-sustituidas; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento del cancer. | |
EP2344642B8 (en) | Novel bacteriophage strains for the treatment of bacterial infections, especially drug resistant strains of the genus enterococcus | |
BR112022012283A2 (pt) | Combinações | |
CL2019001918A1 (es) | Métodos para tratar infecciones bacterianas. | |
ATE533496T1 (de) | Azithromycin zur behandlung von knotiger akne | |
MY166063A (en) | Intravenous antiviral treatments |